A 2-year trend of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Thailand: an alert for infection control

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 5, 2008, Pages 460-464

  Kiratisin, Pattarachai ^a   Chattammanat, Suvikrom ^a   Sa Nguansai, Sunatee ^a   Dansubutra, Boontiwa ^a   Nangpatharapornthawee, Pannipa ^a   Patthamalai, Poramin ^a   Tirachaimongkol, Nuanjutha ^a   Nunthanasup, Thanit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Escherichia coli; Extended spectrum lactamase; Infection control; Klebsiella pneumoniae; Microbial drug resistance; Thailand

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFOXITIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NETILMICIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BLOOD ANALYSIS; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; SPUTUM ANALYSIS; THAILAND; UNIVERSITY HOSPITAL; URINALYSIS;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE; THAILAND;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 41749105756     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.02.005     Document Type: Article

References (18)

1. Ambler R.P., Coulson A.F., Frere J.M., Ghuysen J.M., Joris B., Forsman M., Levesque R.C., Tiraby G., and Waley S.G. A standard numbering scheme for the class A beta-lactamases. Biochem. J. 276 (1991) 269-270
2. Apisarnthanarak A., Kiratisin P., Saifon P., Kitphati R., Dejsirilert S., and Mundy L.M. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am. J. Infect. Control 35 (2007) 606-612
3. Apisarnthanarak A., Kiratisin P., Saifon P., Kitphati R., Dejsirilert S., and Mundy L.M. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand. Infect. Control. Hosp. Epidemiol. 28 (2007) 873-876
4. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14 (2001) 933-951
5. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39 (1995) 1211-1233
6. Chayakulkeeree M., Junsriwong P., Keerasuntonpong A., Tribuddharat C., and Thamlikitkul V. Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003. Southeast Asian J. Trop. Med. Public Health 36 (2005) 1503-1509
7. CLSI, 2007. Performance standards for antimicrobial susceptibility testing; seventeeth informational supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, Pennsylvania, USA.
8. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical microbiologists and infection control specialists. Am. J. Infect. Control 33 (2005) 104-107
9. Hirakata Y., Matsuda J., Miyazaki Y., Kamihira S., Kawakami S., Miyazawa Y., Ono Y., Nakazaki N., Hirata Y., Inoue M., Turnidge J.D., Bell J.M., Jones R.N., Kohno S., and SENTRY Asia-Pacific Participants. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol. Infect. Dis. 52 (2005) 323-329
10. Hyle E.P., Lipworth A.D., Zaoutis T.E., Nachamkin I., Fishman N.O., Bilker W.B., Mao X., and Lautenbach E. Risk factors for increasing multidrug resistance among extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species. Clin. Infect. Dis. 40 (2005) 1317-1324
11. Kiratisin P., Apisarnthanarak A., Saifon P., Laesripa C., Kitphati R., and Mundy L.M. The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn. Microbiol. Infect. Dis. 58 (2007) 349-355
12. Kliebe C., Nies B.A., Meyer J.F., Tolxdorff-Neutzling R.M., and Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob. Agents Chemother. 28 (1985) 302-307
13. Lautenbach E., Strom B.L., Bilker W.B., Patel J.B., Edelstein P.H., and Fishman N.O. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33 (2001) 1288-1294
14. Lautenbach E., Patel J.B., Bilker W.B., Edelstein P.H., and Fishman N.O. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32 (2001) 1162-1171
15. Paterson D.L., and Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18 (2005) 657-686
16. Paterson D.L., Mulazimoglu L., Casellas J.M., Ko W.C., Goossens H., Von Gotteberg A., Mohapatra S., Trenholme G.M., Kugman K.P., McCormack J.G., and Yu V.L. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30 (2000) 473-478
17. Turner P.J. Extended-spectrum beta-lactamases. Clin. Infect. Dis. 41 (2005) S273-S275
18. Winokur P.L., Canton R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32 (2001) S94-S103